New diabetes clinical trial: Improved Treatment and Monitoring of Alzheimer's Disease

Published on: August 21, 2025 at 11:00PM
Conditions: Alzheimer Disease (AD)
Interventions: Drug: Semaglutide (Rybelsus®) combined with other interventions; Other: Placebo; Drug: Semaglutide (Rybelsus®)
Sponsors: Rune Skovgaard Rasmussen; Herlev Hospital
Not yet recruiting
https://ift.tt/Ddi3so2